Company Filing History:
3 out of 2,104 
3 out of 832,880 Years Active: 1997-2009
Title: The Innovative Contributions of Thalia Papayannopoulou
Introduction
Thalia Papayannopoulou is a distinguished inventor based in Seattle, WA, known for her impactful contributions to the field of biomedical research. With a total of six patents to her name, she has been at the forefront of innovative solutions and technologies that advance our understanding of hematopoietic stem cells and gene therapy.
Latest Patents
Among her latest innovations, Papayannopoulou holds a patent titled "Peripheralization of Hematopoietic Stem Cells." This invention focuses on in vivo peripheralization of CD34+ cells through the administration of anti-VLA-4 antibodies or anti-VCAM-1 antibodies, providing a potential breakthrough in stem cell therapies. Additionally, she has developed recombinant adenoviral vectors expressing chimeric fiber proteins for cell-specific infection and genome integration. This invention offers novel chimeric adenoviral vectors that facilitate stable and efficient gene transfer into various cell types or tissues, independent of CAR and αβ interactions. The methods for producing these vectors and their application in targeted gene therapy demonstrate her commitment to advancing medical science.
Career Highlights
Papayannopoulou's career is marked by significant achievements and contributions to the field. She has worked at the University of Washington, where she has collaborated with leading researchers to explore critical advancements in her areas of expertise. Her innovative work has garnered recognition both nationally and internationally.
Collaborations
Throughout her career, Thalia has collaborated with notable scientists, including George Stamatoyannopoulos and André Lieber. These collaborations have propelled forward the research that supports her patented innovations and have influenced the biomedical landscape significantly.
Conclusion
In summary, Thalia Papayannopoulou is a remarkable inventor whose contributions have had a lasting impact on the fields of stem cell research and gene therapy. With her continued commitment to innovation and collaboration, she is poised to make even greater advancements in the years to come.